Comparative effectiveness of alternative intervals between first and second doses of the mRNA COVID-19 vaccines

Abstract The optimal interval between the first and second doses of COVID-19 mRNA vaccines has not been thoroughly evaluated. Employing a target trial emulation approach, we compared the effectiveness of different interdose intervals among >6 million mRNA vaccine recipients in Georgia, USA, from...

Full description

Bibliographic Details
Main Authors: Kayoko Shioda, Alexander Breskin, Pravara Harati, Allison T. Chamberlain, Toshiaki Komura, Benjamin A. Lopman, Elizabeth T. Rogawski McQuade
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-45334-8